Parkhurst NuVision, a San Antonio, Texas-based vision correction facility, has been chosen to perform the highly anticipated national launch of a new permanent contact lens for myopia and astigmatism in one. Dr. Greg Parkhurst will be the first surgeon in the nation to offer the Visian toric ICL to his patients in November 2018. The Visian Toric ICL, a variant of Visian ICL technology created by STAAR Surgical, has been approved by the FDA and allows surgeons to treat astigmatism while simultaneously correcting vision.
The Visian ICL represents a permanent contact lens that has been available for over a decade. The procedure has helped hundreds of thousands of patients enjoy life free from glasses or contacts. However, it has not been a particularly good option for patients with significant astigmatismuntil now, says Greg Parkhurst, MD, a leading San Antonio LASIK specialist and one of the most experienced Visian surgeons in America. With the FDA-approved Visian Toric ICL, surgeons will now be able to use this excellent procedure to treat moderate and even high astigmatism during the vision correction process.
The Visian technology is similar to LASIK in that it is a long-term vision correction solution. During LASIK, the shape of the eyes surface (cornea) is changed to correct the patients vision. The Visian is made of a collagen co-polymer, similar to collagen in the rest of the body, so it is biocompatible. The permanent contact lens is placed just beneath the surface of the eye to achieve vision correction.
The FDAs approval of STAAR Surgicals Visian Toric ICL in the U.S. provides an intuitive treatment option for myopic patients with astigmatism in search of visual freedom, adds STAAR Surgicals President and CEO Caren Mason. We are thrilled to be offering this lens in the United States, and look forward to officially making the Visian Toric ICL available to U.S. surgeons for their patients.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.